The European Parliament’s decision to adopt new rules for the regulation of gene-edited crops marks a turning point that U.S. policymakers, farmers and innovators cannot afford to ignore. That’s according to Lisa Safarian, CEO of Inari, the agricultural biotechnology company.
In an article for Agri-Pulse, Safarian notes that Europe has historically taken a more cautious stance on agricultural biotechnology than many of its global peers. That approach has not only shaped its local farm economy, but also where investments are made, how trade flows and what new tools reach the field. With this new regulation, however, things are about to change.
Visit the Agri-Pulse website to read Lisa’s insights on the impact of this policy change: